HomeNXTG • TLV
add
Nextage Therapeutics Ltd
Previous close
ILA 77.90
Year range
ILA 59.20 - ILA 119.00
Market cap
63.15M ILS
Avg Volume
11.13K
P/E ratio
-
Dividend yield
-
Primary exchange
TLV
Market news
Financials
Income Statement
Revenue
Net income
| (ILS) | 2024info | Y/Y change |
|---|---|---|
Revenue | 413.00K | -52.85% |
Operating expense | 3.52M | -16.55% |
Net income | -3.28M | 15.36% |
Net profit margin | -794.92 | -79.52% |
Earnings per share | — | — |
EBITDA | -3.41M | 13.79% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (ILS) | 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 253.00K | -47.18% |
Total assets | 353.00K | -67.76% |
Total liabilities | 5.89M | 53.68% |
Total equity | -5.54M | — |
Shares outstanding | 33.70M | — |
Price to book | -4.87 | — |
Return on assets | -296.88% | — |
Return on capital | 55.94% | — |
Cash Flow
Net change in cash
| (ILS) | 2024info | Y/Y change |
|---|---|---|
Net income | -3.28M | 15.36% |
Cash from operations | -795.00K | 64.85% |
Cash from investing | -178.00K | -6,033.33% |
Cash from financing | 539.00K | -63.53% |
Net change in cash | -404.00K | 37.56% |
Free cash flow | 502.75K | — |
About
Founded
1982
Website
Employees
31
